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Abstract
Background: Histone H1x is a ubiquitously expressed member of the H1 histone family. H1
histones, also called linker histones, stabilize compact, higher order structures of chromatin. In
addition to their role as structural proteins, they actively regulate gene expression and participate
in chromatin-based processes like DNA replication and repair. The epigenetic contribution of H1
histones to these mechanisms makes it conceivable that they also take part in malignant
transformation.
Methods:  Based on results of a Blast data base search which revealed an accumulation of
expressed sequence tags (ESTs) of H1x in libraries from neuroendocrine tumours (NETs), we
evaluated the expression of H1x in NETs from lung and the gastrointestinal tract using
immunohistochemisty. Relative protein and mRNA levels of H1x were analysed by Western blot
analysis and quantitative real-time RT-PCR, respectively. Since several reports describe a change of
the expression level of the replacement subtype H1.0 during tumourigenesis, the analysis of this
subtype was included in this study.
Results: We found an increased expression of H1x but not of H1.0 in NET tissues in comparison
to corresponding normal tissues. Even though the analysed NETs were heterogenous regarding
their grade of malignancy, all except one showed a considerably higher protein amount of H1x
compared with corresponding non-neoplastic tissue. Furthermore, double-labelling of H1x and
chromogranin A in sections of pancreas and small intestine revealed that H1x is highly expressed
in neuroendocrine cells of these tissues.
Conclusion: We conclude that the high expression of histone H1x in NETs is probably due to the
abundance of this protein in the cells from which these tumours originate.
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Background
The nuclear DNA of eukaryotic cells is organised as chro-
matin in association with proteins. The basal structural
organisation unit of chromatin is the nucleosome consist-
ing of the nucleosome core particle, linker DNA and his-
tone H1. The nucleosome core particle is composed of
two molecules of each of the four core histones which
form an octamer around which DNA with a length of 146
base pairs is wrapped. These nucleosome cores are con-
nected by linker DNA of variable length. H1 histones are
positioned at the linker DNA between the nucleosome
cores and therefore they are also called linker histones
[1,2]. To date, eleven H1 homologous proteins have been
described in humans, including the ubiquitously
expressed subtype H1x [3]. Comparison of the biochemi-
cal behaviour of H1x with other H1 subtypes revealed
similarities but also showed characteristic variations [4].
The regulation of the H1x gene expression differs from
that of the replication-dependent main class subtypes, but
also from that of the replacement subtype H1.0. Interest-
ingly, the activity of H1x seems to be controlled not only
on level of expression, but also by a cell-cycle-dependent
change of its intranuclear distribution [5].
H1 histones actively regulate chromatin processes such as
gene expression [6], DNA replication [7] and repair [8].
Aberrations in such epigenetic mechanisms can be associ-
ated with malignant transformation [9,10]. Since histone
H1 modulates both chromatin structure and transcrip-
tional activity, it is conceivable that H1 histones may con-
tribute to epigenetic phenomena leading to malignant
transformation. Change of the H1 subtype composition
during tumourigenesis has been described in several stud-
ies [11-13]. A greater number of these reports deals with
the replacement H1 subtype H1.0. Some of these data
showed an increase of H1.0, others demonstrated a
decrease in comparison to the paired normal tissue
[14,15]. During our studies on characteristics of the H1
subtype H1x, a Blast data base search revealed an accumu-
lation of expressed sequence tags (ESTs) of H1x in librar-
ies from neuroendocrine tumours (NETs). NETs are a very
heterogenous group of rare epithelial tumours that origi-
nate from neuroendocrine cells and mostly occur in the
gastrointestinal tract and in the lung [16-18]. In the
present study we investigated the occurrence of H1x in
cells of NET tissues using immunohistochemistry and
compared the expression of H1x in NETs with that in
paired normal tissue on protein and on mRNA level using
Western blot analysis and quantitative real-time RT-PCR,
respectively. Furthermore, double labelling of H1x and
chromogranin A, a marker for neuroendocrine cells, of
sections from normal tissue of pancreas and small intes-
tine revealed that H1x is highly expressed in neuroendo-
crine cells of these tissues.
Methods
Bioinformatics
Data base searches were carried out with the Blast pro-
gram http://blast.ncbi.nlm.nih.gov/Blast.cgi.
Tumour samples
Snap-frozen as well as formalin-fixed and paraffin-
embedded tumour samples from 13 primary NETs and
from 1 liver metastasis of a NET were recruited. Paired
non-neoplastic tissues of 8 tissue samples were used as
control (Table 1). Pathohistological examination was per-
formed using haematoxylin-eosin-stained sections of each
specimen. The study was performed according to the eth-
ical guidelines of the Declaration of Helsinki and was
approved by the local ethics committee (no. 32/12/05).
Immunohistochemistry
For immunohistochemical analysis, tissue microarrays
(TMAs) were constructed using a semi-automated manual
tissue arrayer (Alphametrix, Rodgau, Germany) to con-
duct tissue punches with a diameter of 1 mm. For each of
the samples, 6 tissue punches from different areas were
analysed. The 1 μm thick sections were mounted on
sialanised slides, dewaxed, rehydrated and antigen-
retrieved in 10 mM citrate buffer (pH 6.0) for 45 min in a
pressure cooker. The following steps were carried out
using the Dako Cytomation ChemMate Detection Kit
(Dako, Glostrup, Denmark) according to the manufac-
turer's description. The sections were probed with affinity-
purified anti-H1x antibody at a final concentration of 1.5
μg/ml [5] or anti-chromogranin A antibody (DAK-A3,
Dako, Glostrup, Denmark) in a 1:150 dilution. The slides
were counterstained with aniline blue and mounted in
xylol.
Double-labelling experiments
Sections from formalin-fixed and paraffin wax-embedded
samples were deparaffinised in xylol, rehydrated, and
washed in Tris buffered saline (TBS; 50 mM Tris, pH 7.5,
152 mM NaCl). Antigen-retrieval was done by incubation
in 10 mM citrate buffer (pH 6.0) for 45 min at 95°C. Sec-
tions were permeabilised with 0.3% Triton X-100 in TBS
for 45 min and blocked by incubation with 3% BSA in
TBS containing 0.05% Tween-20 (TBS-T). Sections were
then incubated with the following primary antibodies:
Affinity-purified anti-H1x antibody at a final concentra-
tion of 1.5 μg/ml [5] or anti-chromogranin A antibody
(DAK-A3, Dako, Glostrup, Denmark) in a 1:150 dilution.
After washes in TBS (3 × 5 min), sections were incubated
with the following secondary antibodies in a 1:1000 dilu-
tion: Alexa-Fluor 555-anti-mouse IgG (#21425), Alexa
Fluor 488-anti-rabbit IgG (#11070) from Molecular
Probes. Thereafter, sections were rinsed in TBS (3 × 5
min), dehydrated and cleared in xylol. The nuclei were
visualised with the fluorochrome 4'-6-diamidine-2-phe-BMC Cancer 2008, 8:388 http://www.biomedcentral.com/1471-2407/8/388
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nyl indole (DAPI) using Vectashield Mounting Medium
with DAPI (Vector Laboratories, Burlingame, USA). For
fluorescence microscopy an Axioskop (Zeiss, Göttingen,
Germany) was used.
Histone extraction
Purification of whole histones from snap-frozen tissue
samples was done using sulfuric acid. 100 mg tissue was
homogenised in 1 ml PBS, containing protease inhibitors
(Complete, Roche Diagnostics, Mannheim, Germany)
using an ultra turrax. Sulfuric acid was added (final con-
centration 0.2 M) to the homogenate, and histone extrac-
tion was done by incubation for one hour on ice. Samples
were centrifuged (10 min, 4°C, 14,000 × g) and the acid-
soluble proteins in the supernatant were precipitated with
a final concentration of 20% TCA (w/v) for one hour.
After centrifugation (30 min, 4°C, 14,000 × g), the pellet
Table 1: Tumour samples from neuroendocrine tumours (NETs) and paired non-neoplastic tissue samples used in the present study.
Patient no. Sample no. Organ Tissue Subtype
1 1 lung non-neoplastic
1 2 lung NET Carcinoid
2 3 lung non-neoplastic
2 4 lung NET poorly differentiated small cell carcinoma
3 5 lung non-neoplastic
3 6 lung NET carcinoid
4 7 lung NET poorly differentiated small cell carcinoma
5 8 small intestine non-neoplastic
6 9 small intestine non-neoplastic
7 10 small intestine NET well-differentiated carcinoma
8 11 small intestine NET poorly differentiated small cell carcinoma
9 12 small intestine NET well-differentiated carcinoma
10 13 small intestine NET carcinoid
11 14 small intestine NET carcinoid
12 15 pancreas non-neoplastic
13 16 pancreas non-neoplastic
13 17 pancreas NET well-differentiated carcinoma
14 18 pancreas NET poorly differentiated large cell carcinoma
15 19 pancreas NET well-differentiated carcinoma
16 20 pancreas NET well-differentiated carcinoma
17 21 liver non-neoplastic
17 22 liver NET liver metastasis of well-differentiated carcinoma of pancreasBMC Cancer 2008, 8:388 http://www.biomedcentral.com/1471-2407/8/388
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was washed with cold (-20°C) acetone and air-dried. The
histones were dissolved in 30 mM HCl.
Immunoblotting
Histones were separated on 15% SDS-polyacrylamide gels
and electrophoretically transferred to nitrocellulose. Uni-
form blotting was checked by staining the nitrocellulose
filter with Ponceau S (Sigma, Taufkirchen, Germany).
Blots were probed with polyclonal H1x-specific antiserum
in a 1:5000 dilution [4], anti-H1.2 antibody (#ab17677,
Abcam, Cambridge, UK) in a 1:1000 dilution or a mouse
monoclonal anti-H1.0 antibody (kindly provided by Prof.
H. Zentgraf, German Cancer Research Center, Heidelberg,
Germany) in a 1:160 dilution. The immunoreactive pro-
teins were visualized using the chemiluminescence ECL
plus detection system (Amersham Bioscience, Freiburg,
Germany) after incubation with a horseradish peroxidase-
conjugated goat anti-rabbit antibody (#A0545, Sigma,
Taufkirchen, Germany) or horseradish peroxidase-conju-
gated goat anti-mouse antibody (#A9917, Sigma,
Taufkirchen, Germany). Stripping of blotting membranes
for reprobing was done by incubation of the membranes
in stripping buffer (100 mM 2-Mercaptoethanol, 2% SDS,
62.5 mM Tris-HCl, pH 6.7) for 30 min at 50°C with occa-
sional agitation. Bands on the ECL film were quantified
with the 1Dscan Ex gel analysis software (Scanalytics,
Rockville, USA). The ratios of H1x and H1.0 to H1.2 were
calculated, and the mean values of the non-neoplastic tis-
sues were set to 1 to show the fold-change difference of
the protein amounts in the NETs.
Quantitative real-time RT-PCR
Total RNA was extracted from snap-frozen tissue material
with TRIzol reagent (Invitrogen Life Technologies, Man-
nheim, Germany) according to the manufacturer's man-
ual and dissolved in RNase-free water. Total RNA
concentration was quantified with the RNA 6000 nano
LabChip using the Agilent 2100 Bioanalyzer (Agilent
Technologies, Palo Alto, USA). Superscript II RNase H-
Reverse Transcriptase (Invitrogen Life Technologies) was
used to generate first strand cDNA from 5 μg RNA per
sample according to the manual. 125 ng of random hex-
amer primers (Invitrogen Life Technologies) and 40 U of
RNasIn ribonuclease inhibitor (Promega, Mannheim,
Germany) were applied per sample. H1 subtype expres-
sion was analyzed with quantitative real-time RT-PCR
using gene-specific primers (H1x, primer A, CCCAAC-
GATGTAGCGTTTTT, primer B, AAGGCCGAGAGCCAAT-
AGA, amplicon length, 80 bp; H1.2, primer A,
GCCACTTGTACCCGAGTTTT, primer B, TTCTTCTTTA-
CAGGGGCCTTC, amplicon length, 99 bp). Triplicate
PCRs were run in an iCycler (Bio-Rad Laboratories
GmbH, München, Germany) using the Eurogentec qPCR
Core kit for SYBR Green I No ROX (Eurogentec, Seraing,
Belgium) and gene-specific primers in a final concentra-
tion of 300 nmol/l. The temperature profile consisted of
(i) an initial step at 95°C for 10 min; (ii) 40 cycles at 95°C
for 15 s and 60°C for 60 s; and (iii) a final melting curve
analysis with a temperature ramp from 60 to 95°C and a
heating rate of 3°C/min. PCR efficiencies were calculated
with a relative standard curve derived from a cDNA mix-
ture (a twofold dilution series with seven measuring
points in triplicates) and gave regression coefficients
>0.95 and reproducible primer-specific efficiencies of 84–
99%. Gene-specific amplification was confirmed by a sin-
gle peak in melting curve analysis and a single band in
agarose gel electrophoresis. No template controls (no
cDNA in PCR) and genomic controls (no enzyme in
reverse transcription) were run for each gene to detect
unspecific and genomic amplification or primer dimerisa-
tion. Gene expression levels were determined by relative
quantification using the expression of histone H1.2 for
normalization. To compare the Ct-values of the qRT-PCR
results from different samples, the 2-(ΔΔCt)  method
described by [19] was applied. Statistics, Wilcoxon test
and graphs were performed with Statistica 6.0 (StatSoft,
Hamburg, Germany).
Results and discussion
Immunohistochemical detection of H1x in NETs
A Blast data base search revealed a strikingly high portion
of EST entries of the H1 subtype H1x from the libraries
LU24 and LU5 (225 entries of 500 displayed with an E
value of 0.0) which both originated from tissues of neu-
roendocrine lung carcinoids (Cancer Genome Anatomy
Project [20]). In comparison, searches with the sequences
of H1.0 and H1.2 showed no clustering of EST entries in
any library (data not shown). As a consequence of this
result we decided to investigate the occurrence of H1x in
NETs from the lung and the gastrointestinal tract by
immunohistochemistry. Sections of poorly differentiated
neuroendocrine carcinomas of lung and small intestine as
well as of well-differentiated neuroendocrine carcinoma
of pancreas were used (Table 1). Staining of these sections
with affinity-purified H1x-antibody resulted in an inten-
sive and uniform immunoreaction of the tumour cells
(Figure 1). This result demonstrates that H1x is indeed
highly expressed in NETs.
Quantitative analysis
Since the immunohistochemical results showed a high
expression of H1x in neuroendocrine tumour cells we
next performed a quantitative analysis of the H1x expres-
sion on mRNA and on protein level in NET tissues com-
pared with that in the corresponding normal tissue. Since
several reports described a change of the expression level
of the H1 replacement subtype H1.0 during tumourigen-
esis, the relative expression levels of this subtype was also
determined.BMC Cancer 2008, 8:388 http://www.biomedcentral.com/1471-2407/8/388
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The determination of the relative protein amounts of H1x
and H1.0 was done by immunoblotting. Histones were
extracted by acid extraction from snap-frozen tumour
material of neuroendocrine tumours and of the corre-
sponding normal tissue. About equal amounts of H1 his-
tones were loaded, as monitored by detection of the
subtype H1.2 which is considered as one of the basal H1
subtypes detected in all cell types investigated so far
[21,22]. In tissues from lung and small intestine a strik-
ingly higher protein level of H1x was observed in the
tumour tissues compared to the non-neoplastic tissues
(Figures 2A/B, lung, small intestine). Regarding the pan-
creas, one of the non-neoplastic tissues showed a rela-
tively high protein level of H1x whereas in the second
sample from normal tissue the amount of H1x was very
low (Figure 2A, lanes 15 and 16). Even in a liver metasta-
sis of a pancreatic well-differentiated carcinoma, the level
of H1x was higher than in non-neoplastic liver tissue (Fig-
ure 2A, lanes 22 and 23). In conclusion the H1x level was
higher in the NET tissues than in the normal tissues (Fig-
ure 2B). In contrast, no increase in H1.0 protein level in
NETs compared to non-neoplastic tissues was observed
(Figure 2A and 2B, H1.0). The amount of H1.0 in the NET
tissues was partially lower (e.g. Figure 2A, lanes 2 and 3)
and partially higher (e.g. Figure 2A, lanes 5 and 14) than
in the corresponding normal tissues. This observation fits
the result of earlier studies which either found an increase
or a decrease of H1.0 in tumour tissues in comparison to
the paired normal tissues (reviewed in [14]).
The mRNA level of H1x, H1.2 and H1.0 in NET tissues
and non-neoplastic tissues was analysed by quantitative
real-time RT-PCR. The ratios of H1x and H1.0 to the
main-class subtype H1.2 were calculated (Figure 3). A sig-
nificantly higher expression of H1x in the NETs of lung
and small intestine compared to the non-neoplastic tis-
sues was found. However, in the tissue samples of pan-
creas no difference in the H1x expression but a decrease of
the H1.0 expression was observed. Since high protein
amounts of H1x have been determined in the NETs of
pancreas by immunohistochemistry and Western blot
analysis, this result may be explained by a differential pro-
tein turnover or varied kinetics of transcription and trans-
lation like is has been described for the subtype H1.0 [23].
In summary, although the sample size of the present study
was relatively low, these results clearly show an increased
expression of the H1 histone subtype H1x in the analysed
group of NETs compared to the corresponding normal tis-
sues.
Detection of H1x in neuroendocrine cells
The finding that H1x is highly expressed in neuroendo-
crine tumour cells raised the question whether H1x is gen-
erally abundant in neuroendocrine cells. To answer this
question, indirect immunofluorescence double-labelling
of H1x and chromogranin A was performed. Chrom-
ogranin A, a marker protein for neuroendocrine cells, is a
secretory granin protein that is co-stored and co-released
with peptides and amines. It seems to be crucial for the
Immunohistochemical detection of histone H1x in sections  from NET tissues Figure 1
Immunohistochemical detection of histone H1x in 
sections from NET tissues. The three different NETs 
were (A) poorly differentiated carcinoma of lung (Table 1, 
sample no. 4), (B) well-differentiated pancreatic carcinoma 
(sample no. 19) and (C) poorly differentiated carcinoma of 
small intestine (sample no. 11). The tumour cells showed an 
intensive immunoreaction with the anti-H1x antibody. Scale 
bar = 100 μm.BMC Cancer 2008, 8:388 http://www.biomedcentral.com/1471-2407/8/388
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(A) Relative protein amounts of the H1 histone subtypes H1x, H1.2 and H1.0 in non-neoplastic and neuroendocrine tumour  tissues Figure 2
(A) Relative protein amounts of the H1 histone subtypes H1x, H1.2 and H1.0 in non-neoplastic and neuroendo-
crine tumour tissues. Determination of relative protein levels of histone H1x, main type subtype H1.2 and replacement his-
tone H1.0 was done by Western blot analysis. Lane 1, normal tissue of lung (Table 1, sample no. 3), lane 2, neuroendocrine 
carcinoid of lung (no. 2), lane 3, poorly differentiated neuroendocrine small cell carcinoma of lung (no. 4), lane 4, normal tissue 
of lung (no. 5), lane 5, neuroendocrine carcinoid of lung (no. 6), lane 6, poorly differentiated small cell carcinoma of lung (no. 7), 
and lanes 7 and 8, normal tissue of small intestine (no. 8 and 9), lane 9, well-differentiated neuroendocrine carcinoma of small 
intestine (no. 10), lane 10, poorly differentiated neuroendocrine carcinoma (no. 11), and lane 11 well-differentiated neuroendo-
crine carcinoma of small intestine (no. 12), lane 12, normal tissue of small intestine (no. 8), lanes 13 and 14, neuroendocrine 
carcinoid of small intestine (no. 13 and 14), lane 15 and 16, normal tissue of pancreas (no. 15 and 16), lane 17, pancreatic neu-
roendocrine tumour of poor differentiation (no. 18) and lane 18, of good differentiation (no. 19), lane 19, normal tissue of pan-
creas (no. 16), lanes 20 and 21, well-differentiated carcinoma of pancreas (no. 17 and 20), lane 22, normal tissue of liver and 
lane 23, liver metastasis of well-differentiated carcinoma of pancreas (no. 21 and 22). (B) Densitometric quantitation of the 
immunoblots shown in (A). Ratios of H1x and H1.0 to H1.2 were calculated and standard deviations are indicated.BMC Cancer 2008, 8:388 http://www.biomedcentral.com/1471-2407/8/388
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Box plot presentation of the relative RNA levels of H1x and H1.0 determined by quantitative real-time RT-PCR Figure 3
Box plot presentation of the relative RNA levels of H1x and H1.0 determined by quantitative real-time RT-
PCR. Total RNA was extracted from normal lung tissues (Table 1, samples no. 1 and 3), NETs from lung (no. 2 and 4), normal 
tissues from small intestine (no. 8 and 9), NETs from small intestine (no. 10, 11 and 12), normal tissue from pancreas (no. 15) 
and pancreatic NETs (no. 17, 18 and 19) and used for reverse transcription. The generated cDNA from each patient was used 
for triplicate quantitative real-time PCR. Gene expression levels of H1x and H1.0 were determined by relative quantification 
using the expression of histone H1.2 for normalization. Wilcoxon test was used for statistical analysis. The mRNA level of H1x 
was significantly increased in NET tissue of lung (p = 0.004) and small intestine (p = 0.01). Horizontal line, median; inner box, 
25 and 75% interval; outer spread, minimum and maximum.BMC Cancer 2008, 8:388 http://www.biomedcentral.com/1471-2407/8/388
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formation of secretory granules and sequestration of hor-
mones in neuroendocrine cells [24-26]. In pancreatic tis-
sue, scattered chromogranin A-positive cells show a high
protein amount of histone H1x compared to the sur-
rounding chromogranin A-negative cells (Figure 4A).
Interestingly, endocrine cells of islets of Langerhans also
exhibit a relatively high expression of H1x (Figure 4B).
Double-labelling of sections of small intestine revealed
that the chromogranin A-positive neuroendocrine cells
contain higher levels of H1x than the surrounding cells of
the glandulae intestinales (Figure 4C). However, an abun-
dance of H1x was also observed in some cells of the
stroma of the villi. Unfortunalely, analysis of lung tissue
with immunofluorescence labelling was not possible,
since lung sections display a very strong autofluorescence
which is mainly caused by elastin fibers [27,28].
Conclusion
The results of this study clearly show that the H1 subtype
H1x is considerably expressed in neuroendocrine cells of
pancreas and small intestine, and also in endocrine cells
of islets of Langerhans. Thus, the high expression of his-
tone H1x in NETs is probably due to the high expression
of this protein in the cells from which these tumours orig-
inated. Further research into molecular mechanisms by
which H1x exerts its function is needed to find out
whether this increased expression is linked to the endo-
crine function of these cells and/or whether this H1 sub-
type participates in the tumourigenesis of NETs.
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